SCHEMBL7411683

SCHEMBL7411683

CC(C)(N[C@@H](CCC(=O)O)Cc1ccc(-c2ccccc2)cc1)P(=O)(O)O

nearest known ligand 0.66

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MME P08473 5/20 0.60
ACE P12821 3/20 0.48
ACE2 Q9BYF1 1/20 0.47
FFAR1 O14842 1/20 0.47
MMEL1 Q495T6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7411695 1.00 MME (0.60) MMEACEACE2FFAR1MMEL1
SCHEMBL7415381 0.87 MMEL1 (0.50) MMEACEACE2MMEL1
SCHEMBL7415374 0.87 MMEL1 (0.50) MMEACEACE2MMEL1
SCHEMBL7407909 0.85 MME (0.57) MMEACEFFAR1MMEL1
SCHEMBL7407921 0.85 MME (0.57) MMEACEFFAR1MMEL1
SCHEMBL7415260 0.81 MME (0.44) MMEACEACE2MMEL1
SCHEMBL7415269 0.81 MME (0.44) MMEACEACE2MMEL1
SCHEMBL8922396 0.81 MME (0.49) MMEACEMMEL1
SCHEMBL8922371 0.81 MME (0.49) MMEACEMMEL1
SCHEMBL7322706 0.80 MME (0.59) MMEACEACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0660840-B1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES CIBA GEIGY AG (CH) 1997-05-07 EP disclosed
WO-1996026729-A1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES AS ECE INHIBITORS CIBA-GEIGY AG (CH) 1996-09-06 WO disclosed
US-5550119-A ENDOTHELIN-CONVERTING ENZYM INHIBITORS CIBA-GEIGY CORPORATION (US) 1996-08-27 US disclosed
EP-0660840-A1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES. CIBA GEIGY AG (CH) 1995-07-05 EP disclosed
WO-1994005677-A1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES CIBA-GEIGY AG (CH) 1994-03-17 WO disclosed
US-5250522-A Neutral endopeptidase inhibitors; cardiovascular disorders CIBA-GEIGY CORPORATION (US) 1993-10-05 US disclosed